Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

ANIK | Anika Therapeutics Inc.

Healthcare | Medical Devices | USA | NASD

Index	RUT	P/E	-	EPS (ttm)	-1.51	Insider Own	2.78%	Shs Outstand	14.62M	Perf Week	1.80%
Market Cap	272.56M	Forward P/E	-	EPS next Y	-0.66	Insider Trans	0.00%	Shs Float	14.22M	Perf Month	3.44%
Income	-22.17M	PEG	-	EPS next Q	-0.35	Inst Own	92.43%	Short Float / Ratio	6.83% / 4.79	Perf Quarter	-28.29%
Sales	162.11M	P/S	1.68	EPS this Y	-13.07%	Inst Trans	-0.69%	Short Interest	0.97M	Perf Half Y	-33.25%
Book/sh	18.70	P/B	1.00	EPS next Y	42.49%	ROA	-6.49%	Target Price	26.33	Perf Year	-24.18%
Cash/sh	4.45	P/C	4.19	EPS next 5Y	10.00%	ROE	-7.92%	52W Range	16.54 - 32.51	Perf YTD	-37.06%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-7.35%	52W High	-42.69%	Beta	0.75
Dividend %	-	Quick Ratio	4.67	Sales past 5Y	6.89%	Gross Margin	60.90%	52W Low	12.64%	ATR	0.73
Employees	345	Current Ratio	6.49	Sales Q/Q	11.71%	Oper. Margin	-17.67%	RSI (14)	51.15	Volatility	3.16% 4.40%
Optionable	Yes	Debt/Eq	0.11	EPS Q/Q	4.45%	Profit Margin	-13.68%	Rel Volume	0.56	Prev Close	18.88
Shortable	Yes	LT Debt/Eq	0.10	Earnings	Aug 08 AMC	Payout	-	Avg Volume	202.73K	Price	18.63
Recom	1.67	SMA20	4.41%	SMA50	-5.41%	SMA200	-28.34%	Volume	113,383	Change	-1.32%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-14-23	Upgrade	Barrington Research	Mkt Perform → Outperform	$24
Mar-07-23	Downgrade	Barrington Research	Outperform → Mkt Perform
Nov-09-22	Upgrade	Barrington Research	Mkt Perform → Outperform	$31
Oct-14-22	Resumed	Stephens	Equal-Weight	$26
Mar-09-22	Downgrade	Stephens	Overweight → Equal-Weight	$35
Mar-09-22	Downgrade	Barrington Research	Outperform → Mkt Perform
Nov-16-21	Initiated	Stephens	Overweight	$55
Jul-16-21	Initiated	UBS	Neutral	$46
Dec-16-20	Upgrade	Barrington Research	Mkt Perform → Outperform	$43
May-08-20	Downgrade	Barrington Research	Outperform → Mkt Perform
Jan-21-20	Upgrade	Sidoti	Neutral → Buy	$61
Jan-10-20	Upgrade	First Analysis Sec	Outperform → Strong Buy	$65
Nov-05-19	Initiated	BWS Financial	Sell	$29
Sep-24-19	Reiterated	Barrington Research	Outperform	$49 → $58
Sep-23-19	Downgrade	First Analysis Sec	Strong Buy → Outperform	$54
Jul-25-19	Upgrade	First Analysis Sec	Neutral → Strong Buy	$37 → $54
Feb-22-19	Downgrade	Sidoti	Buy → Neutral	$56 → $41
Feb-22-19	Downgrade	First Analysis Sec	Outperform → Neutral	$41 → $37
Jul-27-18	Upgrade	Barrington Research	Mkt Perform → Outperform	$48
Jun-20-18	Downgrade	First Analysis Sec	Overweight → Equal-Weight	$45 → $34

Show Previous Ratings

Sep-19-23 09:00AM	Sidoti Events, LLCs Virtual September Small-Cap Conference (ACCESSWIRE)
09:00AM	Anika Announces the Full Market Release of the RevoMotion Reverse Shoulder Arthroplasty System during the 2023 Orthopaedic Summit: Evolving Technologies (OSET) Annual Meeting (GlobeNewswire)
Sep-15-23 07:44PM	Seagate Stock, Gulfport Energy, and More See Action From Activist Investors (Barrons.com)
04:01PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Sep-12-23 09:00AM	Anika to Participate in the Sidoti Small Cap Virtual Investor Conference (GlobeNewswire)
06:51PM	Loading…
Sep-01-23 06:51PM	Blackstone and Airbnb Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600 (PR Newswire)
09:35AM	Down -20.42% in 4 Weeks, Here's Why You Should You Buy the Dip in Anika (ANIK) (Zacks)
Aug-31-23 12:00PM	All You Need to Know About Anika (ANIK) Rating Upgrade to Buy (Zacks)
09:35AM	Anika (ANIK) Loses -19.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Aug-22-23 07:22AM	3 Sorry Penny Stocks to Sell in August Before Its Too Late (InvestorPlace)
Aug-17-23 06:20PM	Anika Receives 510(k) Clearance for Integrity Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Augmentation of Rotator Cuff Repairs (GlobeNewswire)
11:02AM	Caligan Partners LP Boosts Stake in Anika Therapeutics Inc (GuruFocus.com)
Aug-14-23 09:59AM	Marriott downgraded, Okta upgraded: Wall Street's top analyst calls (The Fly)
Aug-11-23 07:07AM	Anika Therapeutics, Inc.'s (NASDAQ:ANIK) Intrinsic Value Is Potentially 92% Above Its Share Price (Simply Wall St.)
Aug-09-23 09:03AM	Q2 2023 Anika Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
06:55PM	Loading…
Aug-08-23 06:55PM	Anika Therapeutics (ANIK) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
05:40PM	Anika: Q2 Earnings Snapshot (AP Finance)
04:05PM	Anika Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Aug-03-23 07:33PM	10 Oversold Small Cap Stocks To Buy (Insider Monkey)
Jul-20-23 04:05PM	Anika to Issue Second Quarter 2023 Financial Results on Tuesday, August 8, 2023 (GlobeNewswire)
Jul-12-23 09:00AM	Anika Showcases Highly Differentiated Joint Preservation and Restoration Portfolio at the 2023 AOSSM Annual Meeting (GlobeNewswire)
Jun-21-23 08:00PM	ANIK: Lowering target price to $22.00 (Argus Research)
May-30-23 04:05PM	Anika Completes Enrollment in Hyalofast® U.S. Pivotal Phase III Study Achieving Key Milestone (GlobeNewswire)
May-15-23 09:19AM	With 77% ownership of the shares, Anika Therapeutics, Inc. (NASDAQ:ANIK) is heavily dominated by institutional owners (Simply Wall St.)
May-09-23 07:15PM	Anika Therapeutics (ANIK) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
06:08PM	Anika: Q1 Earnings Snapshot (AP Finance)
04:05PM	Anika Reports First Quarter 2023 Financial Results (GlobeNewswire)
Apr-26-23 08:00PM	ANIK: Lowering target price to $28.00 (Argus Research)
Apr-19-23 11:32AM	The past five years for Anika Therapeutics (NASDAQ:ANIK) investors has not been profitable (Simply Wall St.)
08:30AM	Anika to Issue First Quarter 2023 Financial Results on Tuesday, May 9, 2023 (GlobeNewswire)
05:44PM	Loading…
Apr-13-23 05:44PM	UPDATE 1-Anika Therapeutics reaches settlement with activist investor Caligan (Reuters)
05:00PM	Anika Enters Into Cooperation Agreement with Caligan Partners (GlobeNewswire)
Apr-12-23 09:00AM	Anika to Participate in the 22nd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Apr-03-23 09:00AM	Anika Continues to Expand Addressable Market for Tactoset® Injectable Bone Substitute with Additional 510(k) Clearance from FDA (GlobeNewswire)
Mar-27-23 04:55PM	UPDATE 1-Caligan pushes ahead with board challenge at Anika, nominates two directors (Reuters)
04:19PM	Caligan pushes ahead with board challenge at Anika, nominates two directors (Reuters)
08:55AM	Anika Files Preliminary Proxy Statement (GlobeNewswire)
Mar-20-23 06:15PM	Anika Therapeutics (ANIK) Stock Sinks As Market Gains: What You Should Know (Zacks)
02:00PM	Sidoti's Small-Cap Virtual March Conference (ACCESSWIRE)
Mar-18-23 10:08AM	We Think Anika Therapeutics (NASDAQ:ANIK) Can Easily Afford To Drive Business Growth (Simply Wall St.)
08:41AM	Anika Therapeutics Full Year 2022 Earnings: Revenues Beat Expectations, EPS Lags (Simply Wall St.)
Mar-15-23 04:01PM	Anika to Participate in the Sidoti Small Cap Virtual Investor Conference (GlobeNewswire)
Mar-08-23 10:00AM	Anika Highlights Products in High Growth Segments of Joint Preservation during the 2023 AAOS Annual Meeting (GlobeNewswire)
07:21AM	Anika Therapeutics, Inc. (NASDAQ:ANIK) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-07-23 09:52AM	Q4 2022 Anika Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents) -10.25%
Mar-06-23 05:45PM	Anika Therapeutics (ANIK) Reports Q4 Loss, Tops Revenue Estimates (Zacks) -8.61%
04:41PM	Anika: Q4 Earnings Snapshot (AP Finance)
04:05PM	Anika Reports Fourth Quarter and Year-End Fiscal 2022 Financial Results (GlobeNewswire)
Feb-28-23 09:00AM	Anika to Participate in the Canaccord Genuity Musculoskeletal Conference (GlobeNewswire)
Feb-27-23 06:15PM	Anika Therapeutics (ANIK) Outpaces Stock Market Gains: What You Should Know (Zacks)
Feb-21-23 06:15PM	Anika Therapeutics (ANIK) Gains As Market Dips: What You Should Know (Zacks)
10:51AM	UPDATE 2-Caligan urges Anika Therapeutics to conduct review, plans board challenge (Reuters)
10:30AM	Anika to Issue Fourth Quarter and Year-End 2022 Financial Results on Monday, March 6, 2023 (GlobeNewswire)
10:00AM	Anika Issues Statement (GlobeNewswire)
08:00AM	Caligan Partners Issues Open Letter to Anika Board (PR Newswire)
Feb-20-23 09:25AM	Anika (ANIK) to Report Q4 Earnings: What's in the Cards? (Zacks)
Feb-14-23 06:15PM	Anika Therapeutics (ANIK) Gains As Market Dips: What You Should Know (Zacks)
Feb-13-23 08:30AM	Anika Announces First Surgeries Performed Using the New RevoMotion Reverse Shoulder Arthroplasty System and Commences Limited Market Release in the United States (GlobeNewswire)
Feb-07-23 06:15PM	Anika Therapeutics (ANIK) Outpaces Stock Market Gains: What You Should Know (Zacks)
Jan-30-23 06:15PM	Anika Therapeutics (ANIK) Dips More Than Broader Markets: What You Should Know (Zacks)
Jan-17-23 09:40AM	Is Anika Therapeutics (ANIK) Stock Outpacing Its Medical Peers This Year? (Zacks)
Jan-09-23 10:04AM	Biogen (BIIB), Eisai's Lecanemab Gets FDA Nod for Alzheimer's (Zacks)
Dec-28-22 07:05AM	Multiple insiders bought Anika Therapeutics, Inc. (NASDAQ:ANIK) stock earlier this year, a positive sign for shareholders (Simply Wall St.)
Nov-10-22 01:24PM	7 Stocks to Buy Before the Market Starts to Soar in 2023 (InvestorPlace) +7.80%
Nov-08-22 07:35PM	Anika Therapeutics (ANIK) Reports Q3 Loss, Tops Revenue Estimates (Zacks) -7.28%
04:05PM	Anika Reports Third Quarter Fiscal 2022 Financial Results (GlobeNewswire)
Nov-01-22 12:14PM	Anika Therapeutics Cingal Tops Steroid For Osteoarthritis Pain Relief (Benzinga) +5.67%
08:00AM	Anikas Cingal® Successfully Achieves Primary Endpoint in Third Phase III Study (GlobeNewswire)
Oct-25-22 09:25AM	Anika to Issue Third Quarter 2022 Financial Results on Tuesday, November 8, 2022 (GlobeNewswire) +5.01%
Oct-17-22 01:13PM	The past five years for Anika Therapeutics (NASDAQ:ANIK) investors has not been profitable (Simply Wall St.)
Oct-11-22 09:41AM	Immatics (IMTX) Moves 11.6% Higher: Will This Strength Last? (Zacks)
Sep-12-22 04:01PM	Anika Announces First Surgeries Performed Using the X-Twist Fixation System and Commences Limited Market Release (GlobeNewswire)
Aug-03-22 05:45PM	Anika Therapeutics (ANIK) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Anika Reports Second Quarter Fiscal 2022 Financial Results (GlobeNewswire)
Jul-27-22 09:15AM	Anika Receives the ACE Award for Cutting-Edge Innovation for Tactoset® Injectable Bone Substitute from the American Orthopedic Society for Sports Medicine (GlobeNewswire)
Jul-21-22 07:20AM	Bullish insiders at Anika Therapeutics, Inc. (NASDAQ:ANIK) loaded up on US$573k of stock earlier this year (Simply Wall St.)
Jul-19-22 10:42AM	Ultragenyx (RARE) Provides Update From Angelman Syndrome Study (Zacks)
Jul-12-22 05:05PM	Anika to Issue Second Quarter 2022 Financial Results on Wednesday, August 3, 2022 (GlobeNewswire)
Jun-14-22 02:45PM	Sidoti's Summer Small Cap Virtual Conference (ACCESSWIRE)
Jun-10-22 09:27AM	Anika to Participate in the Sidoti Small Cap Virtual Investor Conference (GlobeNewswire)
May-20-22 03:07PM	New FDA 510(k) Clearance Expands Anika's Sports Medicine Soft Tissue Portfolio (Benzinga)
07:00AM	Anika Receives FDA 510(k) Clearance for the X-Twist Knotless Fixation System, Expanding its Sports Medicine Soft Tissue Portfolio (GlobeNewswire)
May-13-22 05:00PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-10-22 10:50AM	Anika Therapeutics (NASDAQ:ANIK) shareholders have endured a 56% loss from investing in the stock five years ago (Simply Wall St.)
May-09-22 04:05PM	Anika to Participate in the UBS Global Healthcare Conference 2022 (GlobeNewswire)
May-05-22 04:05PM	Anika Reports First Quarter Fiscal 2022 Financial Results (GlobeNewswire) -6.97%
May-04-22 07:55AM	Techne (TECH) Beats Q3 Earnings and Revenue Estimates (Zacks)
Apr-26-22 07:24AM	New Strong Sell Stocks for April 26th (Zacks)
Apr-19-22 05:50AM	New Strong Sell Stocks for April 19th (Zacks)
Apr-15-22 05:00PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Apr-07-22 04:05PM	Anika to Issue First Quarter 2022 Financial Results on Thursday, May 5, 2022 (GlobeNewswire)
07:04AM	New Strong Sell Stocks for April 7th (Zacks)
Apr-04-22 04:05PM	Anika to Participate in the 21st Annual Needham Virtual Healthcare Conference (GlobeNewswire)
07:57AM	New Strong Sell Stocks for April 4th (Zacks)
Mar-28-22 10:48AM	New Strong Sell Stocks for March 28th (Zacks)
Mar-23-22 08:30AM	Anika to Showcase its Transformation into a Global Leader in Joint Preservation during the 2022 AAOS Annual Meeting (GlobeNewswire)
Mar-21-22 09:41AM	New Strong Sell Stocks for March 21st (Zacks)
Mar-15-22 07:00PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Mar-10-22 04:05PM	Anika to Participate in the Canaccord Genuity Musculoskeletal Conference (GlobeNewswire) -5.80%
Mar-08-22 04:05PM	Anika Reports Fourth Quarter and Year-End 2021 Financial Results (GlobeNewswire)

Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company's main focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and its products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika Therapeutics was founded in 1992 and is headquartered in Bedford, MA.

Insider Trading	Relationship	Date	Transaction	#Shares	#Shares Total	SEC Form 4
Levitz Michael L	EVP, CFO, Treasurer	Aug 10	Option Exercise	3,859	34,365	Aug 11 04:30 PM
Blanchard Cheryl R	President, CEO, Director	Apr 26	Option Exercise	24,575	125,155	Apr 28 04:30 PM
Blanchard Cheryl R	President, CEO, Director	Mar 10	Option Exercise	30,060	113,791	Mar 14 04:46 PM
Colleran David	EVP, General Counsel, Corp Sec	Mar 10	Option Exercise	7,663	22,538	Mar 14 04:46 PM
Levitz Michael L	EVP, CFO, Treasurer	Mar 10	Option Exercise	8,888	32,447	Mar 14 04:47 PM
Levitz Michael L	EVP, CFO, Treasurer	Mar 09	Option Exercise	4,439	24,862	Mar 10 04:52 PM
Blanchard Cheryl R	President, CEO, Director	Mar 09	Option Exercise	14,419	87,963	Mar 10 04:51 PM
Colleran David	EVP, General Counsel, Corp Sec	Mar 09	Option Exercise	3,683	15,956	Mar 10 04:51 PM
Colleran David	EVP, General Counsel, Corp Sec	Mar 04	Option Exercise	2,500	13,007	Mar 07 04:34 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ANIK | Anika Therapeutics Inc.

Upgrade your FINVIZ experience